Works matching DE "CANCER in dogs"

Results: 501

Doxorubicin area under the curve is an important predictor of neutropenia in dogs with naturally occurring cancers.

Published in:

Veterinary & Comparative Oncology, 2019, v. 17, n. 2, p. 147, doi. 10.1111/vco.12455

By:

Wittenburg, Luke A.;
Weishaar, Kristen;
Ramirez, Dominique;
Gustafson, Daniel L.

Publication type:

Article

ZEB1 and ZEB2 transcription factors are potential therapeutic targets of canine mammary cancer cells.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 596, doi. 10.1111/vco.12427

By:

Xavier, Pedro L. P.;
Cordeiro, Yonara G.;
Rochetti, Arina L.;
Sangalli, Juliano R.;
Zuccari, Debora A. P. C.;
Silveira, Juliano C.;
Bressan, Fabiana F.;
Fukumasu, Heidge

Publication type:

Article

Clinical features and outcome of dermal squamous cell carcinoma in 193 dogs (1987‐2017).

Published in:

Veterinary & Comparative Oncology, 2019, v. 17, n. 2, p. 130, doi. 10.1111/vco.12461

By:

Willcox, Jennifer L.;
Marks, Stanley L.;
Ueda, Yu;
Skorupski, Katherine A.

Publication type:

Article

Targeting NEDD8‐activating enzyme is a new approach to treat canine diffuse large B‐cell lymphoma.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 606, doi. 10.1111/vco.12428

By:

Assumpção, A. L. F. V.;
Lu, Z.;
Marlowe, K. W.;
Shaffer, K. S.;
Pan, X.

Publication type:

Article

Anticancer effects of high‐dose ascorbate on canine melanoma cell lines.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 616, doi. 10.1111/vco.12429

By:

Shin, Hyeri;
Nam, Aryung;
Song, Kun‐ho;
Lee, Kupil;
Rebhun, Robert B.;
Seo, Kyoung‐won

Publication type:

Article

Canine T cell lymphoma treated with lomustine, vincristine, procarbazine, and prednisolone chemotherapy in 35 dogs.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 622, doi. 10.1111/vco.12430

By:

Morgan, E.;
O'connell, K.;
Thomson, M.;
Griffin, A.

Publication type:

Article

Primary pulmonary histiocytic sarcoma in dogs: A retrospective analysis of 37 cases (2000‐2015).

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 658, doi. 10.1111/vco.12437

By:

Marlowe, Katelyn W.;
Robat, Cecilia S.;
Clarke, Dawn M.;
Taylor, Angela;
Touret, Maude;
Husbands, Brian D.;
Vail, David M.

Publication type:

Article

Evaluation of intravenous and subcutaneous administration of a novel, excipient‐free, nanoparticulate formulation of paclitaxel in dogs with spontaneously occurring neoplasia.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 650, doi. 10.1111/vco.12435

By:

Selting, Kim A.;
Bechtel, Sandra M.;
Espinosa, Jahna;
Henry, Carolyn J.;
Tate, Deborah;
Bryan, Jeffrey N.;
Rajewski, Lian;
Flesner, Brian K.;
Decedue, Charles;
Baltezor, Michael

Publication type:

Article

Anti‐tumour effect of lapatinib in canine transitional cell carcinoma cell lines.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 642, doi. 10.1111/vco.12434

By:

Sakai, Kosei;
Maeda, Shingo;
Saeki, Kohei;
Nakagawa, Takayuki;
Murakami, Mami;
Endo, Yoshifumi;
Yonezawa, Tomohiro;
Kadosawa, Tsuyoshi;
Mori, Takashi;
Nishimura, Ryohei;
Matsuki, Naoaki

Publication type:

Article

Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 630, doi. 10.1111/vco.12432

By:

Rico, Charlène;
Boerboom, Derek;
Paquet, Marilène

Publication type:

Article

Therapeutic impact of regional lymphadenectomy in canine stage II cutaneous mast cell tumours.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 580, doi. 10.1111/vco.12425

By:

Marconato, Laura;
Polton, Gerry;
Stefanello, Damiano;
Morello, Emanuela;
Ferrari, Roberta;
Henriques, Joaquim;
Tortorella, Giovanni;
Benali, Silvia L.;
Bergottini, Raffaella;
Vasconi, Maria E.;
Annoni, Maurizio;
Sabattini, Silvia

Publication type:

Article

In vitro and in vivo activity of liposome‐encapsulated curcumin for naturally occurring canine cancers.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 571, doi. 10.1111/vco.12424

By:

Withers, Sita S.;
York, Daniel;
Johnson, Eric;
Al‐nadaf, Sami;
Skorupski, Katherine A.;
Rodriguez, Carlos O.;
Burton, Jenna H.;
Guerrero, Teri;
Sein, Kriste;
Wittenburg, Luke;
Rebhun, Robert B.

Publication type:

Article

Preliminary investigation of extracellular vesicles in mammary cancer of dogs and cats: Identification and characterization.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 489, doi. 10.1111/vco.12405

By:

Sammarco, A.;
Finesso, G.;
Cavicchioli, L.;
Ferro, S.;
Caicci, F.;
Zanetti, R.;
Sacchetto, R.;
Zappulli, V.

Publication type:

Article

Combination therapy of canine osteosarcoma with canine bone marrow stem cells, bone morphogenetic protein and carboplatin in an in vivo model.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 478, doi. 10.1111/vco.12404

By:

Rici, R. E. G.;
Will, S. E. A. L.;
Luna, A. C. L.;
Melo, L. F.;
Santos, A. C.;
Rodrigues, R. F.;
Leandro, R. M.;
Maria, D. A.

Publication type:

Article

Pre‐clinical evaluation of proteasome inhibitors for canine and human osteosarcoma.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 544, doi. 10.1111/vco.12413

By:

Patatsos, K.;
Shekhar, T. M.;
Hawkins, C. J.

Publication type:

Article

Comparison of minichromosome maintenance protein 7, Ki67 and mitotic index in the prognosis of intermediate Patnaik grade cutaneous mast cell tumours in dogs.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 535, doi. 10.1111/vco.12412

By:

Berlato, D.;
Murphy, S.;
Laberke, S.;
Rasotto, R.

Publication type:

Article

Outcome and prognostic factors in medically treated canine prostatic carcinomas: A multi‐institutional study.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 450, doi. 10.1111/vco.12400

By:

Ravicini, S.;
Baines, S. J.;
Taylor, A.;
Amores‐fuster, I.;
Mason, S. L.;
Treggiari, E.

Publication type:

Article

Does the tumour microenvironment alter tumorigenesis and clinical response in transmissible venereal tumour in dogs?

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 3, p. 370, doi. 10.1111/vco.12388

By:

Ballestero Fêo, H.;
Montoya Flórez, L.;
Yamatogi, R. S.;
Prado Duzanski, A.;
Araújo, J. P.;
Oliveira, R. A.;
Rocha, N. S.

Publication type:

Article

Prognostic significance of histopathology in canine anal sac gland adenocarcinomas: Preliminary results in a retrospective study of 39 cases.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 518, doi. 10.1111/vco.12410

By:

Pradel, J.;
Berlato, D.;
Dobromylskyj, M.;
Rasotto, R.

Publication type:

Article

Comparison between May‐Grünwald‐Giemsa and rapid cytological stains in fine‐needle aspirates of canine mast cell tumour: Diagnostic and prognostic implications.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 511, doi. 10.1111/vco.12409

By:

Sabattini, S.;
Renzi, A.;
Marconato, L.;
Militerno, G.;
Agnoli, C.;
Barbiero, L.;
Rigillo, A.;
Capitani, O.;
Tinto, D.;
Bettini, G.

Publication type:

Article

The impact of extirpation of non‐palpable/normal‐sized regional lymph nodes on staging of canine cutaneous mast cell tumours: A multicentric retrospective study.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 505, doi. 10.1111/vco.12408

By:

Ferrari, R.;
Marconato, L.;
Buracco, P.;
Boracchi, P.;
Giudice, C.;
Iussich, S.;
Grieco, V.;
Chiti, L. E.;
Favretto, E.;
Stefanello, D.

Publication type:

Article

Dosimetric benefit of adaptive radiotherapy in the neoadjuvant management of canine and feline thymoma—An exploratory case series.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 3, p. 324, doi. 10.1111/vco.12382

By:

Rohrer Bley, C.;
Meier, V.;
Schneider, U.

Publication type:

Article

Survival times in dogs with presumptive intracranial gliomas treated with oral lomustine: A comparative retrospective study (2008‐2017).

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 459, doi. 10.1111/vco.12401

By:

Moirano, S. J.;
Dewey, C. W.;
Wright, K. Z.;
Cohen, P. W.

Publication type:

Article

A single dose of intravenous combretastatin A4‐phosphate is reasonably well tolerated and significantly reduces tumour vascularization in canine spontaneous cancers.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 467, doi. 10.1111/vco.12402

By:

Abma, E.;
De Spiegelaere, W.;
Vanderperren, K.;
Stock, E.;
Van Brantegem, L.;
Cornelis, I.;
Daminet, S.;
Ni, Y.;
Vynck, M.;
Verstraete, G.;
Smets, P.;
De Rooster, H.

Publication type:

Article

Pathological features of intestinal T‐cell lymphoma in Shiba dogs in Japan.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 417, doi. 10.1111/vco.12396

By:

Matsumoto, I.;
Uchida, K.;
Nakashima, K.;
Goto‐koshino, Y.;
Chambers, J. K.;
Tsujimoto, H.;
Nakayama, H.

Publication type:

Article

Corrigendum.

Published in:: 2018
Publication type:: Correction Notice

Prognostic significance of hypermethylation of death‐associated protein kinase (DAPK) gene CpG island in dogs with high‐grade B‐cell lymphoma.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 3, p. 409, doi. 10.1111/vco.12395

By:

Sato, M.;
Mochizuki, H.;
Goto‐koshino, Y.;
Fujiwara‐igarashi, A.;
Takahashi, M.;
Ohno, K.;
Tsujimoto, H.

Publication type:

Article

Inter‐ and intra‐rater reliability and agreement in determining subcutaneous tumour margins in dogs.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 3, p. 392, doi. 10.1111/vco.12394

By:

Ranganathan, B.;
Milovancev, M.;
Leeper, H.;
Townsend, K. L.;
Bracha, S.;
Curran, K.

Publication type:

Article

Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 3, p. 399, doi. 10.1111/vco.12393

By:

Polton, G.;
Finotello, R.;
Sabattini, S.;
Rossi, F.;
Laganga, P.;
Vasconi, M. E.;
Barbanera, A.;
Stiborova, K.;
Rohrer Bley, C.;
Marconato, L.

Publication type:

Article

Checkpoint molecule expression by B and T cell lymphomas in dogs.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 3, p. 352, doi. 10.1111/vco.12386

By:

Hartley, G.;
Elmslie, R.;
Dow, S.;
Guth, A.

Publication type:

Article

Association of tumour‐infiltrating regulatory T cells with adverse outcomes in dogs with malignant tumours.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 3, p. 330, doi. 10.1111/vco.12383

By:

Sakai, K.;
Maeda, S.;
Yamada, Y.;
Chambers, J. K.;
Uchida, K.;
Nakayama, H.;
Yonezawa, T.;
Matsuki, N.

Publication type:

Article

Biodistribution and tolerance of intravenous iodine‐131‐labelled hypericin in healthy dogs.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 3, p. 318, doi. 10.1111/vco.12381

By:

Abma, E.;
Peremans, K.;
De Vos, F.;
Bosmans, T.;
Kitshoff, A. M.;
Daminet, S.;
Ni, Y.;
Dockx, R.;
De Rooster, H.

Publication type:

Article

Prognostic significance of clinical presentation, induction and rescue treatment in 42 cases of canine centroblastic diffuse large B‐cell multicentric lymphoma in the United Kingdom.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 2, p. 276, doi. 10.1111/vco.12378

By:

Davies, O.;
Szladovits, B.;
Polton, G.;
Garden, O. A.;
Leo, C.;
Lara‐Garcia, A.

Publication type:

Article

In vitro efficacy of a first‐generation valosin‐containing protein inhibitor (CB‐5083) against canine lymphoma.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 3, p. 311, doi. 10.1111/vco.12380

By:

Gareau, A.;
Rico, C.;
Boerboom, D.;
Nadeau, M.‐e.

Publication type:

Article

Preliminary investigation of blood concentrations of insulin‐like growth factor, insulin, lactate and β‐hydroxybutyrate in dogs with lymphoma as compared with matched controls.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 2, p. 262, doi. 10.1111/vco.12376

By:

McQuown, B.;
Burgess, K. E.;
Heinze, C. R.

Publication type:

Article

Aberrant expression of microRNAs and the miR‐1/MET pathway in canine hepatocellular carcinoma.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 2, p. 288, doi. 10.1111/vco.12379

By:

Lai, Y.‐C.;
Ushio, N.;
Rahman, M. M.;
Katanoda, Y.;
Ogihara, K.;
Naya, Y.;
Moriyama, A.;
Iwanaga, T.;
Saitoh, Y.;
Sogawa, T.;
Sunaga, T.;
Momoi, Y.;
Izumi, H.;
Miyoshi, N.;
Endo, Y.;
Fujiki, M.;
Kawaguchi, H.;
Miura, N.

Publication type:

Article

Oncolytic reovirus therapy: Pilot study in dogs with spontaneously occurring tumours.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 2, p. 229, doi. 10.1111/vco.12361

By:

Hwang, C. C.;
Igase, M.;
Sakurai, M.;
Haraguchi, T.;
Tani, K.;
Itamoto, K.;
Shimokawa, T.;
Nakaichi, M.;
Nemoto, Y.;
Noguchi, S.;
Coffey, M.;
Okuda, M.;
Mizuno, T.

Publication type:

Article

Anticancer effects of resveratrol in canine hemangiosarcoma cell lines.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 2, p. 253, doi. 10.1111/vco.12375

By:

Carlson, A.;
Alderete, K. S.;
Grant, M. K. O.;
Seelig, D. M.;
Sharkey, L. C.;
Zordoky, B. N. M.

Publication type:

Article

Gain‐of‐function mutation in PTPN11 in histiocytic sarcomas of Bernese Mountain Dogs.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 2, p. 220, doi. 10.1111/vco.12357

By:

Thaiwong, T.;
Sirivisoot, S.;
Takada, M.;
Yuzbasiyan‐Gurkan, V.;
Kiupel, M.

Publication type:

Article

Modulation of fatty acid metabolism and immune suppression are features of in vitro tumour sphere formation in ontogenetically distinct dog cancers.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. E176, doi. 10.1111/vco.12368

By:

Kim, J.-H.;
Frantz, A. M.;
Sarver, A. L.;
Gorden Klukas, B. H.;
Lewellen, M.;
O'Brien, T. D.;
Dickerson, E. B.;
Modiano, J. F.

Publication type:

Article

The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. 55, doi. 10.1111/vco.12311

By:

Keller, Alexandra;
Wingelhofer, Bettina;
Peter, Barbara;
Bauer, Karin;
Berger, Daniela;
Gamperl, Susanne;
Reifinger, Martin;
Cerny-Reiterer, Sabine;
Moriggl, Richard;
Willmann, Michael;
Valent, Peter;
Hadzijusufovic, Emir

Publication type:

Article

Safety evaluation of combination carboplatin and toceranib phosphate (Palladia) in tumour-bearing dogs: A phase I dose finding study.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. E52, doi. 10.1111/vco.12332

By:

Wouda, R. M.;
Hocker, S. E.;
Higginbotham, M. L.

Publication type:

Article

Metastasis-associated microRNA expression in canine uveal melanoma.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. 81, doi. 10.1111/vco.12315

By:

Starkey, M. P.;
Compston-Garnett, L.;
Malho, P.;
Dunn, K.;
Dubielzig, R.

Publication type:

Article

Metastatic diagnosis of canine sternal lymph nodes using computed tomography characteristics: A retrospective cross-sectional study.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. 140, doi. 10.1111/vco.12323

By:

Iwasaki, R.;
Murakami, M.;
Kawabe, M.;
Heishima, K.;
Sakai, H.;
Mori, T.

Publication type:

Article

Engineered cross-reacting nanobodies simplify comparative oncology between humans and dogs.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. E202, doi. 10.1111/vco.12359

By:

Mazzega, E.;
de Marco, A.

Publication type:

Article

Role of monocyte recruitment in hemangiosarcoma metastasis in dogs.

Published in:

Veterinary & Comparative Oncology, 2017, v. 15, n. 4, p. 1309, doi. 10.1111/vco.12272

By:

Regan, D. P.;
Escaffi, A.;
Coy, J.;
Kurihara, J.;
Dow, S. W.

Publication type:

Article

Apoptotic intrinsic pathway proteins predict survival in canine cutaneous mast cell tumours.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. E38, doi. 10.1111/vco.12330

By:

Barra, C. N.;
Macedo, B. M.;
Cadrobbi, K. G.;
Pulz, L. H.;
Huete, G. C.;
Kleeb, S. R.;
Xavier, J. G.;
Catão-Dias, J. L.;
Nishiya, A. T.;
Fukumasu, H.;
Strefezzi, R. F.

Publication type:

Article

Risk factors for treatment-related adverse events in cancer-bearing dogs receiving piroxicam.

Published in:

Veterinary & Comparative Oncology, 2017, v. 15, n. 4, p. 1346, doi. 10.1111/vco.12276

By:

Eichstadt, L. R.;
Moore, G. E.;
Childress, M. O.

Publication type:

Article

Retrospective evaluation of blood copper stable isotopes ratio <sup>65</sup>Cu/<sup>63</sup>Cu as a biomarker of cancer in dogs.

Published in:

Veterinary & Comparative Oncology, 2017, v. 15, n. 4, p. 1323, doi. 10.1111/vco.12273

By:

Chamel, G.;
Gourlan, A. T.;
Télouk, P.;
Sayag, D.;
Milliard, V.;
Loiseau, C.;
Simon, M.;
Buff, S.;
Ponce, F.

Publication type:

Article

Sequence analysis of RAS and RAF mutation hot spots in canine carcinoma.

Published in:

Veterinary & Comparative Oncology, 2017, v. 15, n. 4, p. 1598, doi. 10.1111/vco.12275

By:

Mochizuki, H.;
Breen, M.

Publication type:

Article